Clinical and biochemical parameters of study subjects by group.

<p>Data represented by mean ± standard deviation;</p>a<p>indicates group significantly different from control;</p>b<p>indicates group significantly different from obese without diabetes;</p>c<p>indicates group significantly different from non-obese diabetes;</p>d<p>indicates group significantly different from obese diabetes. Level of significance is given at p≤0.05. Abbreviations: BMI, body mass index; SAD, sagittal abdominal diameter; LDL, low-density lipoprotein; HDL, high-density lipoprotein.</p

Serum levels of FABP4, LCN2 and RBP4 in obese subjects with or without diabetes and in CVD patients.

<p>The CVD group had significantly higher level of serum RBP4 compared to any of the other groups. FABP4 values were significantly higher in obese, obese diabetic and CVD subjects compared to control and non-obese diabetic groups. LCN2 values were higher in CVD subjects than any of the others but this difference did not reach statistical significance (P = 0.46).</p

Establishment of principal components.

<p>Eigen vectors (factor loadings for standardized variables) for first two principal components.</p

Pearson correlations of CVD component 1 and BMI with anthropometric and biochemical parameters in CVD subjects.

<p>Pearson correlations of CVD component 1 and BMI with anthropometric and biochemical parameters in CVD subjects.</p

Correlation analysis of anthropometric and clinical parameters with serum RBP4, FABP4 and LCN2.

<p>Correlation analysis of anthropometric and clinical parameters with serum RBP4, FABP4 and LCN2.</p